Foghorn Therapeutics Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Foghorn Therapeutics Inc. (FHTX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 21.54 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- Foghorn Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 21.31M shares, a 97.20% increase year-over-year.
- Foghorn Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 10.80M shares, a 12.35% increase year-over-year.
- Foghorn Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 9.62M shares, a 0.71% decline year-over-year.
- Foghorn Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 9.68M shares, a 24.31% increase year-over-year.
- Foghorn Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 10.28M shares, a 14.07% increase from fiscal 2024.
- Foghorn Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 9.01M shares, a 0.43% increase from fiscal 2023.
- Foghorn Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 8.97M shares, a 13.12% increase from fiscal 2022.
- Foghorn Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 7.93M shares, a 33.52% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 21.54M shares 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 21.31M shares 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 10.28M shares 10-K · filed 2026-03-11 | |||
| 2025-09-30 | 10.64M shares 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | 10.83M shares 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | 10.80M shares 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 9.01M shares 10-K · filed 2026-03-11 | |||
| 2024-09-30 | 9.04M shares 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | 9.25M shares 10-Q · filed 2025-08-05 | |||
| 2024-03-31 | 9.62M shares 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | 8.97M shares 10-K · filed 2025-03-06 | |||
| 2023-09-30 | 9.55M shares 10-Q · filed 2024-11-04 | |||
| 2023-06-30 | 9.76M shares 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | 9.68M shares 10-Q · filed 2024-05-06 | |||
| 2022-12-31 | 7.93M shares 10-K · filed 2024-03-07 | |||
| 2022-09-30 | 7.88M shares 10-Q · filed 2023-11-02 | |||
| 2022-06-30 | 7.87M shares 10-Q · filed 2023-08-04 | |||
| 2022-03-31 | 7.79M shares 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | 5.94M shares 10-K · filed 2023-03-09 | |||
| 2021-09-30 | 6.25M shares 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | 6.40M shares 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | 6.32M shares 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | 5.03M shares 10-K/A · filed 2022-08-09 | |||
| 2020-09-30 | 27.12M shares 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | 23.38M shares 10-Q · filed 2021-08-10 | |||
| 2020-03-31 | 19.94M shares 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | 20.25M shares 10-K · filed 2021-03-18 | |||
| 2019-09-30 | 20.67M shares 10-Q · filed 2020-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |